The store will not work correctly when cookies are disabled.
2-(1H-Benzimidazol-1-yl)-N-[(hydroxy-(5-nitrothiophen-2-yl)methyl)]-acetamide
ID: ALA454419
PubChem CID: 25110574
Max Phase: Preclinical
Molecular Formula: C14H12N4O4S
Molecular Weight: 332.34
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(Cn1cnc2ccccc21)NC(O)c1ccc([N+](=O)[O-])s1
Standard InChI: InChI=1S/C14H12N4O4S/c19-12(7-17-8-15-9-3-1-2-4-10(9)17)16-14(20)11-5-6-13(23-11)18(21)22/h1-6,8,14,20H,7H2,(H,16,19)
Standard InChI Key: KCXWDZYHSXIASG-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
15.6685 -26.2482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1886 -26.8915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0038 -26.7621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9616 -25.4793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7748 -25.3467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3018 -25.9891 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0757 -25.6864 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.0271 -24.8568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2230 -24.6469 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.7704 -26.1313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5030 -25.7522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1976 -26.1971 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.5410 -24.9281 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.9302 -25.8179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6250 -26.2629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9682 -24.9939 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.6767 -27.0836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4748 -27.2921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9197 -26.5973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3965 -25.9597 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
23.7470 -26.5457 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.1168 -25.8083 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.2007 -27.2347 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10 11 1 0
11 12 1 0
2 3 1 0
11 13 2 0
3 6 2 0
12 14 1 0
1 2 2 0
14 15 1 0
5 4 2 0
14 16 1 0
15 17 2 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 15 1 0
4 1 1 0
7 10 1 0
5 6 1 0
21 22 2 0
21 23 1 0
19 21 1 0
M CHG 2 21 1 23 -1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 332.34 | Molecular Weight (Monoisotopic): 332.0579 | AlogP: 1.81 | #Rotatable Bonds: 5 |
Polar Surface Area: 110.29 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.58 | CX Basic pKa: 5.55 | CX LogP: 1.76 | CX LogD: 1.75 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.42 | Np Likeness Score: -1.87 |
References
1. Saczewski F, Stencel A, Bieńczak AM, Langowska KA, Michaelis M, Werel W, Hałasa R, Reszka P, Bednarski PJ.. (2008) Structure-activity relationships of novel heteroaryl-acrylonitriles as cytotoxic and antibacterial agents., 43 (9): [PMID:18187237] [10.1016/j.ejmech.2007.11.017] |